WALTHAM, Mass.- PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, today reported financial results for the second quarter ended July 1, 2012. The Company reported GAAP earnings per share from continuing operations of $0.29, as compared to $0.26 in the second quarter of 2011. […]

Sunnyvale, CA,: Molecular Devices, LLC, today announced the launch of MetaXpress® 5.0 High Content Image Acquisition and Analysis Software, which has been designed to improve the ease and speed of custom analysis using the Company’s ImageXpress® Micro and Ultra Systems. The new software enables user-created analysis to be run on MetaXpress PowerCore™ Software, which harnesses […]

Cynvenio Biosystems, Inc., a developer of rare cell isolation systems for biomedical research, personalized medicine and molecular diagnosis of cancer, today announced that the National Cancer Institute (NCI) awarded the company a $1.4 million Phase II Small Business Innovative Research (SBIR) contract to partially fund the development and commercialization of a novel microfluidic technology for […]

CORNING, N.Y., — Corning Incorporated (NYSE: GLW) today announced the recipients of its 2012 “Color the Community Orange” program. The annual program grants laboratory supplies to local area high schools where Corning Life Sciences employees work or live. This year, five schools each received about $4,000 worth of laboratory products. Each school is also eligible […]

Westlake Village, CA —— Cynvenio Biosystems, Inc., a developer of rare cell isolation systems for biomedical research, personalized medicine and molecular diagnosis of cancer, today announced the ability to enable next generation sequencing of rare cell populations without the need for additional amplification steps. Cynvenio’s automated LiquidBiopsy™ cell isolation platform recovers circulating tumor cells (CTCs) […]

Cambridge, UK,: Horizon Discovery (Horizon), a leading provider of research tools to support the development of personalized medicines, today announced that it has signed a technology access agreement with the U.S. National Institutes of Health Center for Regenerative Medicine (NIH CRM), through Horizon’s Centers of Excellence (CoE) program. The agreement will enable the NIH CRM […]

WALTHAM, Mass.–Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the second quarter ended June 30, 2012. “We executed well to deliver another strong quarter of revenue and earnings growth” Second Quarter Highlights • Adjusted earnings per share (EPS) grew 23% to a second quarter record […]

Sunnyvale, CA, – Molecular Devices, LLC, today announced the formation of its Scientific Advisory Board (SAB). Comprising experts from a range of fields including stem cell research, biotherapeutics and cell signalling, the SAB will advise on strategy, product applications and product innovation, with the aim of identifying evolving customer needs and ensuring that the Molecular […]

Franklin Lakes, NJ – The Board of Directors of BD (Becton, Dickinson and Company) (NYSE:BDX) has declared a quarterly dividend of 45 cents per common share, payable on September 28, 2012 to holders of record on September 7, 2012. The indicated annual dividend rate is $1.80 per share. About BD BD is a leading global […]

Golden, Colorado —— Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced an expanded relationship with a key distributor of its stem cell-based products, privately-held Neuromics, Inc (www.neuromics.com). Vitro Biopharma officials recently met Neuromics principals at their corporate headquarters in Minneapolis, MN. Neuromics was formed in 2005 by Pete Shuster, a marketing and sales professional […]